Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
37,764,404
-
Shares change
-
-119,405
-
Total reported value, excl. options
-
$237,662,655
-
Value change
-
-$338,194
-
Put/Call ratio
-
30.6%
-
Number of buys
-
46
-
Number of sells
-
-58
-
Price
-
$6.28
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q3 2021
146 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q3 2021.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,764,404 shares
of 113,177,462 outstanding shares and own 33.37% of the company stock.
Largest 10 shareholders include ArrowMark Colorado Holdings LLC (7,993,211 shares), BlackRock Inc. (5,121,133 shares), STATE STREET CORP (4,042,251 shares), VANGUARD GROUP INC (3,364,952 shares), Park West Asset Management LLC (1,668,587 shares), GEODE CAPITAL MANAGEMENT, LLC (1,187,322 shares), Nuveen Asset Management, LLC (1,113,372 shares), FIERA CAPITAL CORP (1,069,010 shares), NORTHERN TRUST CORP (973,507 shares), and TWO SIGMA ADVISERS, LP (938,828 shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.